These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1296493)

  • 21. [Evaluation of clinical tolerability and diagnostic efficacy of ioversol 350 in UIV. A randomized double-blind study of ioversol 350 versus iohexol 350].
    Voegeli E; Woessmer B
    Ann Radiol (Paris); 1992; 35(4 Pt 2):293-6. PubMed ID: 1296495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ioversol 300: clinical study in pediatric intravenous urography].
    Montagne J; Adamsbaum C
    Ann Radiol (Paris); 1992; 35(4 Pt 2):307-10. PubMed ID: 1296498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of contrast material for spiral CT of the abdomen: comparison of hepatic enhancement and vascular attenuation for three different contrast media at two different delay times.
    Herts BR; Paushter DM; Einstein DM; Zepp R; Friedman RA; Obuchowski N
    AJR Am J Roentgenol; 1995 Feb; 164(2):327-31. PubMed ID: 7839963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical profile of ioversol. A metaanalysis of 57 randomized, double-blind clinical trials.
    Floriani I; Ciceri M; Torri V; Tinazzi A; Jahn H; Noseda A
    Invest Radiol; 1996 Aug; 31(8):479-91. PubMed ID: 8854194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of ioversol by hemodialysis.
    Ueda J; Furukawa T; Takahashi S; Sakaguchi K
    Acta Radiol; 1996 Sep; 37(5):826-9. PubMed ID: 8915301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adverse reactions following high-dose intravenous injection of urographic contrast media].
    Lackner K; Köster O; von Uexküll V; Broich H
    Rofo; 1984 Oct; 141(4):447-52. PubMed ID: 6436920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse reactions to nonionic iodine in contrast-enhanced computed tomography: usefulness of monitoring vital signs.
    Kurabayashi T; Ida M; Fukayama H; Ohbayashi N; Yoshino N; Sasaki T
    Dentomaxillofac Radiol; 1998 Jul; 27(4):199-202. PubMed ID: 9780895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intravenous contrast medium application in elderly patients -- evaluation of Iopentol (Imagopaque 300)].
    Rathsmann P; Jacobs GF; Müller RD
    Rofo; 2004 Dec; 176(12):1826-31. PubMed ID: 15573295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind comparative study of the safety, tolerability, and efficacy of ioversol and iohexol in peripheral and visceral arteriography.
    Cutcliff WB; Schwarten DE
    Invest Radiol; 1989 Jun; 24 Suppl 1():S56-9. PubMed ID: 2687198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unequal doses of ioversol versus diatrizoate for urography.
    Baker MK; Kopecky KK; Bogan M; Wass JL
    Urol Radiol; 1990; 12(3):168-72. PubMed ID: 2281582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical summary of initial intravenous administration of ioversol.
    McClennan BL
    Invest Radiol; 1989 Jun; 24 Suppl 1():S43-6. PubMed ID: 2687195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-related nephrotoxicity.
    Rosovsky M; Rusinek H
    Radiology; 2006 Aug; 240(2):614. PubMed ID: 16864686
    [No Abstract]   [Full Text] [Related]  

  • 33. [Adverse reactions and intracranial contrast medium after myelography].
    Fujii K; Hashimoto T; Isaza M; Hashimoto T; Hirabuki N; Miura T; Mitomo M; Kozuka T; Kawai R
    Rinsho Hoshasen; 1989 Mar; 34(3):323-7. PubMed ID: 2739082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a life-threatening anaphylactoid reaction following administration of ioversol in a child.
    Zuckerman GB; Riess PL; Patel L; Constantinescu AR; Rosenfeld DL
    Pediatr Radiol; 1999 Apr; 29(4):295-7. PubMed ID: 10199911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with ioversol 320 in cranial computed tomographic scanning.
    Sartor K; Gado MH; Hodges FJ
    Invest Radiol; 1989 Jun; 24 Suppl 1():S29-32. PubMed ID: 2687191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonionic contrast media in pediatric CT. A comparative study of intravenous use of iopentol and iohexol.
    Wiklund LM; Brolin I; Sjöholm K
    Acta Radiol; 1994 Mar; 35(2):186-90. PubMed ID: 8172749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast medium tolerance in computed tomography.
    Tschakert H
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():156-61. PubMed ID: 6139072
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of nonionic contrast media in computerized tomography].
    Langer M; Felix R; Behrends B; Eichstädt H
    Digitale Bilddiagn; 1987 Mar; 7(1):25-9. PubMed ID: 3568544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium.
    Shaw DD; Bach-Gansmo T; Dahlstrom K
    Invest Radiol; 1985; 20(1 Suppl):S44-50. PubMed ID: 3882616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nausea and vomiting after exposure to non-ionic contrast media: incidence and risk factors focusing on preparatory fasting.
    Kim YS; Yoon SH; Choi YH; Park CM; Lee W; Goo JM
    Br J Radiol; 2018 Jul; 91(1087):20180107. PubMed ID: 29694239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.